-
$RUBY enters a Downtrend as Momentum Indicator dropped below the 0 level on January 21, 2020. View odds for this and other indicators: https://tickeron.com/go/1210173#RubiusTherapeutics#stockmarket#stock#technicalanalysis#money#trading#investing#daytrading#news#todaypic.twitter.com/Fiyt5svaLh
-
Rubius Therapeutics
$RUBY Lifted to “Hold” at BidaskClub http://zolmax.com/?p=3617808 -
#PrivateTrader#Live Stocks trades: Value entered$IMTKA$MOD, Genetics exited$RUBY. I benched these positions: Growth$AMED, Momentum$CYH, Robotics$SPLK.https://timbovee.com/2020/02/04/live-tuesday-february-4-2020/ … -
$RUBY: New Insider Filing on Chief Financial Officer ANDREW M. OH: http://insideri.com/1746614_000110465920010062_0001104659-20-010062 … -
#PrivateTrader#Live In stocks, I've changed my stop/loss model. No exits this morning. I entered three positions in the Genetics Portfolio:$AAPL$GH$RUBY. https://timbovee.com/2020/02/03/live-monday-february-3-2020/ … -
Rubius Therapeutics Inc
$RUBY Receives Consensus Rating of “Buy” from Analysts http://baseballnewssource.com/?p=3935458 -
Rubius Therapeutics
$RUBY Raised to “Buy” at Zacks Investment Research http://zpr.io/tKyzi -
Baird
$RUBY Even with the trial start, we remain critical of RUBY’s RCT platform, particularly with the lack of visibility on timing for clinical data from this study. We thus reiterate our RUBY Underperform rating, $3 price target, and RUBY’s status as a bearish Fresh Pick. -
Congrats to Rubius for actually dosing a patient finally
$RUBY pic.twitter.com/deWGXXkcr1
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.